PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, offering promising advancements across various clinical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA provides a safer, a lot more reputable substitute for therapeutic use, si